Join
Live feed
·
PRReleasevia Quantisnow
I-MAB logo

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

ByQuantisnow·Wall Street's wire, on your screen.
IMAB· I-MAB
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMAB (I-MAB) and more on Quantisnow.